Trial Profile
Efficacy and safety of emtricitabine/rilpivirine/tenofovir disoproxil fumarate in virologically suppressed patients with HIV infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 09 Nov 2015 New trial record